Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice

Xudong Wu, Katherine A. Steigelman, Erik Bonten, Huimin Hu, Wenxuan He, Tianying Ren, Jian Zuo, Alessandra d'Azzo

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The neuraminidase-1 (Neu1) knockout mouse model is a phenocopy of the lysosomal storage disease (LSD) sialidosis, characterized by multisystemic and neuropathic symptoms, including hearing loss. We have characterized the auditory defects in Neu1-/- mice and found that hearing loss involves both conductive and sensorineural components. Auditory brainstem response (ABR) thresholds were significantly elevated in Neu1-/- mice at P21 (48 -55 dB), and hearing loss appeared progressive (53 -66 dB at P60). At these ages Neu1-/- mice accumulated cerumen in the external ear canal and had a thickened mucosa and inflammation in the middle ear. In cochleae of adult wild-type mice, Neu1 was expressed in several cell types in the stria vascularis, the organ of Corti, and spiral ganglion. Progressive morphological abnormalities such as extensive vacuolization were detected in the Neu1-/- cochleae as early as P9. These early morphologic changes in Neu1-/- cochleae were associated with oversialylation of several lysosomal associated membrane proteins (Lamps) in the stria vascularis. A marked increase in the expression and apical localization of Lamp-1 in marginal cells of the stria vascularis predicts exacerbation of lysosomal exocytosis into the endolymph. Consequently, the endolymphatic potential in Neu1-/- mice was reduced by approximately 20 mV at ages P31-P44, which would cause dysfunction of transduction in sensory hair cells. This study suggests a molecular mechanism that contributes to hearing loss in sialidosis and identifies potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)259-268
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1802
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Lysosome-Associated Membrane Glycoproteins
Cochlea
Neuraminidase
Hearing Loss
Stria Vascularis
Mucolipidoses
Cerumen
Endolymph
Spiral Ganglion
Lysosomal Storage Diseases
Organ of Corti
Ear Canal
Brain Stem Auditory Evoked Potentials
Exocytosis
Otitis Media
Knockout Mice
Mucous Membrane

Keywords

  • Cochlea
  • Endolymphatic potential
  • Hearing loss
  • Lysosomes
  • Sialidosis

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. / Wu, Xudong; Steigelman, Katherine A.; Bonten, Erik; Hu, Huimin; He, Wenxuan; Ren, Tianying; Zuo, Jian; d'Azzo, Alessandra.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1802, No. 2, 02.2010, p. 259-268.

Research output: Contribution to journalArticle

Wu, Xudong ; Steigelman, Katherine A. ; Bonten, Erik ; Hu, Huimin ; He, Wenxuan ; Ren, Tianying ; Zuo, Jian ; d'Azzo, Alessandra. / Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2010 ; Vol. 1802, No. 2. pp. 259-268.
@article{7e98b172459a4f40b02d2a99ebe010f0,
title = "Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice",
abstract = "The neuraminidase-1 (Neu1) knockout mouse model is a phenocopy of the lysosomal storage disease (LSD) sialidosis, characterized by multisystemic and neuropathic symptoms, including hearing loss. We have characterized the auditory defects in Neu1-/- mice and found that hearing loss involves both conductive and sensorineural components. Auditory brainstem response (ABR) thresholds were significantly elevated in Neu1-/- mice at P21 (48 -55 dB), and hearing loss appeared progressive (53 -66 dB at P60). At these ages Neu1-/- mice accumulated cerumen in the external ear canal and had a thickened mucosa and inflammation in the middle ear. In cochleae of adult wild-type mice, Neu1 was expressed in several cell types in the stria vascularis, the organ of Corti, and spiral ganglion. Progressive morphological abnormalities such as extensive vacuolization were detected in the Neu1-/- cochleae as early as P9. These early morphologic changes in Neu1-/- cochleae were associated with oversialylation of several lysosomal associated membrane proteins (Lamps) in the stria vascularis. A marked increase in the expression and apical localization of Lamp-1 in marginal cells of the stria vascularis predicts exacerbation of lysosomal exocytosis into the endolymph. Consequently, the endolymphatic potential in Neu1-/- mice was reduced by approximately 20 mV at ages P31-P44, which would cause dysfunction of transduction in sensory hair cells. This study suggests a molecular mechanism that contributes to hearing loss in sialidosis and identifies potential therapeutic targets.",
keywords = "Cochlea, Endolymphatic potential, Hearing loss, Lysosomes, Sialidosis",
author = "Xudong Wu and Steigelman, {Katherine A.} and Erik Bonten and Huimin Hu and Wenxuan He and Tianying Ren and Jian Zuo and Alessandra d'Azzo",
year = "2010",
month = "2",
doi = "10.1016/j.bbadis.2009.10.008",
language = "English (US)",
volume = "1802",
pages = "259--268",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice

AU - Wu, Xudong

AU - Steigelman, Katherine A.

AU - Bonten, Erik

AU - Hu, Huimin

AU - He, Wenxuan

AU - Ren, Tianying

AU - Zuo, Jian

AU - d'Azzo, Alessandra

PY - 2010/2

Y1 - 2010/2

N2 - The neuraminidase-1 (Neu1) knockout mouse model is a phenocopy of the lysosomal storage disease (LSD) sialidosis, characterized by multisystemic and neuropathic symptoms, including hearing loss. We have characterized the auditory defects in Neu1-/- mice and found that hearing loss involves both conductive and sensorineural components. Auditory brainstem response (ABR) thresholds were significantly elevated in Neu1-/- mice at P21 (48 -55 dB), and hearing loss appeared progressive (53 -66 dB at P60). At these ages Neu1-/- mice accumulated cerumen in the external ear canal and had a thickened mucosa and inflammation in the middle ear. In cochleae of adult wild-type mice, Neu1 was expressed in several cell types in the stria vascularis, the organ of Corti, and spiral ganglion. Progressive morphological abnormalities such as extensive vacuolization were detected in the Neu1-/- cochleae as early as P9. These early morphologic changes in Neu1-/- cochleae were associated with oversialylation of several lysosomal associated membrane proteins (Lamps) in the stria vascularis. A marked increase in the expression and apical localization of Lamp-1 in marginal cells of the stria vascularis predicts exacerbation of lysosomal exocytosis into the endolymph. Consequently, the endolymphatic potential in Neu1-/- mice was reduced by approximately 20 mV at ages P31-P44, which would cause dysfunction of transduction in sensory hair cells. This study suggests a molecular mechanism that contributes to hearing loss in sialidosis and identifies potential therapeutic targets.

AB - The neuraminidase-1 (Neu1) knockout mouse model is a phenocopy of the lysosomal storage disease (LSD) sialidosis, characterized by multisystemic and neuropathic symptoms, including hearing loss. We have characterized the auditory defects in Neu1-/- mice and found that hearing loss involves both conductive and sensorineural components. Auditory brainstem response (ABR) thresholds were significantly elevated in Neu1-/- mice at P21 (48 -55 dB), and hearing loss appeared progressive (53 -66 dB at P60). At these ages Neu1-/- mice accumulated cerumen in the external ear canal and had a thickened mucosa and inflammation in the middle ear. In cochleae of adult wild-type mice, Neu1 was expressed in several cell types in the stria vascularis, the organ of Corti, and spiral ganglion. Progressive morphological abnormalities such as extensive vacuolization were detected in the Neu1-/- cochleae as early as P9. These early morphologic changes in Neu1-/- cochleae were associated with oversialylation of several lysosomal associated membrane proteins (Lamps) in the stria vascularis. A marked increase in the expression and apical localization of Lamp-1 in marginal cells of the stria vascularis predicts exacerbation of lysosomal exocytosis into the endolymph. Consequently, the endolymphatic potential in Neu1-/- mice was reduced by approximately 20 mV at ages P31-P44, which would cause dysfunction of transduction in sensory hair cells. This study suggests a molecular mechanism that contributes to hearing loss in sialidosis and identifies potential therapeutic targets.

KW - Cochlea

KW - Endolymphatic potential

KW - Hearing loss

KW - Lysosomes

KW - Sialidosis

UR - http://www.scopus.com/inward/record.url?scp=74149087076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74149087076&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2009.10.008

DO - 10.1016/j.bbadis.2009.10.008

M3 - Article

VL - 1802

SP - 259

EP - 268

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 2

ER -